Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-009085

Chief Operating Officer sold 3,125 shares at an average $8.60 ($26,863)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2023-04-10 Sale 10b5-1 −817 $8.50 $6,945 177,669 D
ADAMS R MARK Chief Operating Officer 2023-04-11 Sale 10b5-1 −2,308 $8.63 $19,918 175,361 D
Open-market sales · 3,125 sh · avg $8.60 · $26,863
Loading xslF345X04/form4.xml…